Atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ?Symptomatic paroxysmal atrial fibrillation with at least 2 episodes in the past 6 months and at least 1 episode confirmed by ECG. ?No age limit, male or female. ?No acupuncture treatment within the previous 6 month. ?Cooperating with 8 weeks treatment and follow-up. ?Signed written informed consent.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had any of the following ?Secondary atrial fibrillation. ?Catheter ablation or cardiac surgery within the last 3 months. ?Severe heart failure (New York Heart Association (NYHA)III or IV). ?In the absence of a pacemaker, patients with sick sinus syndrome, II or III degree atrioventricular block. ?Echocardiography: left ventricular ejection fraction 5.5cm. ?Have severe lung, liver, kidney disease or other serious primary disease. ?Skin allergy to ECG monitoring electrodes. ?Patients enrolled in other clinical trials within the last 1 month. ?Patients enrolled in other clinical trials within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of AF burden compared to baseline at 6 months; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate variability;Quality of life evaluation;Times to hospitalizations for cardiac arrhythmias.;The maximum daily duration of AF during monitoring.;Total duration of atrial fibrillation during monitoring;European Heart Rhythm Society (EHRA) Atrial fibrillation symptom score.;Average heart rate;Change from baseline in AF burden at the end of treatment; | — |
Countries
China